Growth Metrics

Soleno Therapeutics (SLNO) Return on Assets (2016 - 2025)

Soleno Therapeutics (SLNO) has disclosed Return on Assets for 8 consecutive years, with 0.04% as the latest value for Q4 2025.

  • Quarterly Return on Assets changed N/A to 0.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.04% through Dec 2025, changed N/A year-over-year, with the annual reading at 0.04% for FY2018, 12.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.04% at Soleno Therapeutics, up from 0.07% in the prior quarter.
  • The five-year high for Return on Assets was 0.04% in Q4 2025, with the low at 0.37% in Q1 2025.